The American Journal of Pathology
Volume 180, Issue 4 , Pages 1581-1592, April 2012

Partial Loss of Epithelial Phenotype in Kindlin-1–Deficient Keratinocytes

Center for Biochemistry, Medical Faculty, University of Cologne, Cologne, Germany

Accepted 3 January 2012. published online 10 February 2012.

Kindlin-1 is an adaptor protein that is expressed by most epithelial cells and has been implicated in integrin bidirectional signaling. Mutations in the gene encoding kindlin-1 are associated with Kindler syndrome, a recessively inherited disorder that is characterized by fragile skin. Functionally, a loss of kindlin-1 impairs the adhesion of basal keratinocytes to the extracellular matrix both in vivo and in vitro. In this study, we show that the phenotype of mutant keratinocytes deficient in kindlin-1 is characterized by the modification of the cortical actin network and increased plasticity of the plasma membrane. At the molecular level, expression of several proteins associated with an epithelial phenotype, such as α6β4 integrin, collagen XVII, E-cadherin, and desmoglein-3, is strongly reduced, whereas, surprisingly, laminin 332 is synthesized in larger amounts than in control keratinocytes. In contrast, mesenchymal markers such as vimentin and fibronectin are increased in keratinocytes lacking kindlin-1. The switch in cell plasticity and protein expression was confirmed by siRNA-mediated down-regulation of kindlin-1 in HaCaT epithelial cells. Furthermore, there was up-regulation of matrix metalloproteinases and pro-inflammatory cytokines in kindlin-1–deficient keratinocytes. These results provide new insights into the pathogenic mechanisms that take place in Kindler syndrome. Moreover, the constellation of molecular defects associated with the loss of kindlin-1 may explain the higher incidence of skin cancer observed in patients affected with this disorder.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by grants from the Federal Ministry for Education and Research (Networks Epidermolysis bullosa, 01GM0832, and Stem Cell Therapy for Severe Skin Fragility Syndromes, 01GN0972), the Marga und Boll Stiftung, and the Köln Fortune program from the Medical Faculty of the University of Cologne. M.A. is a researcher from the Centre National de la Recherche Scientifique.

 Supplemental material for this article can be found at http://ajp.amjapthol.org or at doi: 10.1016/j.ajpath.2012.01.005.

PII: S0002-9440(12)00040-5

doi:10.1016/j.ajpath.2012.01.005

The American Journal of Pathology
Volume 180, Issue 4 , Pages 1581-1592, April 2012